May 20−22, 2022, Annual Meeting

European Society for Pediatric Dermatology (ESPD)

May 12−14, 2021, Virtual Meeting

European Society for Pediatric Dermatology (ESPD)

European Society for Pediatric Dermatology (ESPD)

Poster icon

Ligelizumab in adolescent patients with chronic spontaneous urticaria: Results from a dedicated phase 2b study

P. Staubach, M. Alvaro-Lozano, B. E. Sekerel, M. Maurer, M. Ben-Shoshan, A. Drollmann,
A. Bienczak, M. Porter, T. Liu, A. Burciu
Poster icon

Study design and rationale of a phase 2b dose-finding study of ligelizumab in adolescent patients with chronic spontaneous urticaria

B. E. Şekerel, A. Drollmann, M. Porter, N. Kataoka, A. Bienczak, M. Maurer, P. Staubach, M. Ben-Shoshan, R. Janocha, T. Severin

2019

2018

No publication submitted this year

© Copyright 2024 Novartis Pharma AG